Alnylam Pharmaceuticals, Inc. - Common Stock (NQ:ALNY)Price and VolumeDetailed Quote
Top NewsMore News
Top US Stock Gainers and Losers for Oct. 29, 2026 ↗
October 29, 2026
Via Chartmill
Performance
52-Week Range
66.6% below 52-week high
160.22
156.0052W Low
479.7952W High
1 Week
31.2% below 1-week high
156.001W Low
232.881W High
Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY) traded between $156.00 and $479.79 over the past 52 weeks and last traded at $160.22, 66.6% below its 52-week high. Over the past week it ranged between $156.00 and $232.88.
Past 12 Months
-29.4%
-27.1%
-27.3%
-46.2%
-60.0%
-63.1%
1W
-$66.56
1M
-$59.66
3M
-$60.11
6M
-$137.70
YTD
-$239.95
1Y
-$273.85
ALNY was -63.1% over the past year, -46.2% over six months, -60.0% year to date, -29.4% in the last week.
12 Months vs Market
ALNY
DIA
SPY
QQQ
IWM
Over the past 12 months ALNY returned -63.1% versus DIA (Dow) +9.2%, SPY (S&P 500) +10.4%, QQQ (Nasdaq 100) +8.4% and IWM (Russell 2000) +14.1%.
Volume & Liquidity
1.31× 3-mo avg
Today 2,455,134
3-mo avg 1.9M
1W
1M
3M
6M
YTD
1Y
ALNY most recently traded 2,455,134 shares against a 3-month average daily volume of 1.9M. More NewsRead More
Alnylam (ALNY) Q3 2026 Earnings Call Transcript ↗
October 29, 2026
Via The Motley Fool
Topics
Earnings
Alnylam Pharmaceuticals (NASDAQ:ALNY): Affordable Growth in Biotech ↗
September 03, 2026
Via Chartmill
Alnylam Pharmaceuticals Q3 Earnings Call Highlights ↗
October 29, 2026
Via MarketBeat
Topics
Earnings
Premarket Gainers and Losers on Oct. 29, 2026 ↗
October 29, 2026
Via Chartmill
Via MarketBeat
Alnylam vs. Ionis: Here's the Better Bad-News Buy ↗
October 10, 2026
Via The Motley Fool
18 of 21 Analysts Still Think Alnylam Stock Is a Buy. Here's Why They're Right. ↗
September 28, 2026
Via The Motley Fool
Alnylam Highlights AMVUTTRA Momentum, Resets 2026 TTR Revenue Outlook ↗
September 20, 2026
Via MarketBeat
Alnylam’s Zilebesiran Targets Twice-Yearly Blood Pressure Control in ZENITH Trial ↗
September 19, 2026
Via MarketBeat
Topics
Death
Alnylam to Webcast Presentations at Upcoming September Investor Conferences
September 02, 2026
Via Business Wire
Frequently Asked QuestionsIs Alnylam Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Alnylam Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Alnylam Pharmaceuticals, Inc. - Common Stock trade on?
Alnylam Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Alnylam Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Alnylam Pharmaceuticals, Inc. - Common Stock is ALNY on the Nasdaq Stock Market
What is the current price of Alnylam Pharmaceuticals, Inc. - Common Stock?
The current price of Alnylam Pharmaceuticals, Inc. - Common Stock is 160.22
When was Alnylam Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Alnylam Pharmaceuticals, Inc. - Common Stock was at 11/03/26 03:24 PM ET
What is the market capitalization of Alnylam Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Alnylam Pharmaceuticals, Inc. - Common Stock is 19.04B
How many shares of Alnylam Pharmaceuticals, Inc. - Common Stock are outstanding?
Alnylam Pharmaceuticals, Inc. - Common Stock has 19B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>